Who owns Biomarin Pharma Inc convertible/?
- CUSIP Number: 09061gah4
Tip: Access positions for across all investors
Analyze quarterly positions in Biomarin Pharma Inc convertible/ with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Biomarin Pharma Inc convertible/ stock
Who bought or sold Biomarin Pharma Inc convertible/ this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Lord, Abbett & Co | 43M | $42M | 259% | Mar 2024 |
|
Bank of America Corporation | 30M | $30M | 127% | Mar 2024 |
|
Millennium Management | 27M | $26M | 5% | Mar 2024 |
|
Citigroup | 26M | $25M | 3% | Mar 2024 |
|
Aviva | 26M | $25M | 2% | Mar 2024 |
|
Sona Asset Management | 25M | $25M | 8% | Mar 2024 |
|
Tenor Capital Management | 22M | $21B | 639% | Mar 2024 |
|
Shaolin Capital Management | 17M | $17M | 325% | Mar 2024 |
|
Sunrise Partners Limited Partnership | 15M | $15M | 40% | Mar 2024 |
|
Partner Fund Management | 15M | $15M | 0% | Dec 2023 |
|
Moore Capital Management | 13M | $13M | 100% | Mar 2024 |
|
Thrivent Financial for Lutherans | 10M | $10M | 0% | Mar 2024 |
|
MacKay Shields | 8.8M | $8.7M | -3% | Mar 2024 |
|
Jpmorgan Chase & Co | 8.4M | $8.3M | -19% | Mar 2024 |
|
Palisade Capital Management | 8.0M | $7.8M | -8% | Mar 2024 |
|
Opti Capital Management | 7.6M | $7.5M | 100% | Mar 2024 |
|
Man Group | 7.5M | $7.4M | 0% | Mar 2024 |
|
Royal Bank of Canada | 6.7M | $6.7M | 1% | Mar 2024 |
|
Sonora Investment Management Group | 6.1M | $6.0M | -3% | Mar 2024 |
|
Wells Fargo & Company | 5.2M | $5.1M | 50% | Mar 2024 |
|
DLD Asset Management | 5.0M | $4.9M | 100% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 4.3M | $4.2M | -11% | Mar 2024 |
|
Bnp Paribas Investment Partners | 3.5M | $3.4M | 0% | Mar 2024 |
|
Jane Street | 2.6M | $2.5M | -4% | Mar 2024 |
|
Leucadia National Corporation | 2.5M | $2.5M | 1465% | Mar 2024 |
|
Lazard Asset Management | 2.5M | $2.5M | 0% | Dec 2023 |
|
Morgan Stanley | 2.3M | $2.3M | -83% | Mar 2024 |
|
Bank Of Montreal | 2.1M | $2.1M | -36% | Mar 2024 |
|
Citadel Advisors | 2.0M | $2.0M | -50% | Mar 2024 |
|
Branch Banking & Trust Company | 2.0M | $1.9M | -9% | Mar 2024 |
|
Nicholas Investments Partners | 1.7M | $1.7M | 0% | Dec 2023 |
|
Barclays | 1.3M | $1.2M | 11% | Mar 2024 |
|
Prospector Partners | 1.2M | $1.2M | 0% | Mar 2024 |
|
Edmond De Rothschild Holding | 1.1M | $1.1M | 0% | Mar 2024 |
|
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 1.0M | $984k | 100% | Mar 2024 |
|
Calamos Advisors | 980k | $964k | -95% | Mar 2024 |
|
Axa | 771k | $759k | 0% | Mar 2024 |
|
Loomis, Sayles and | 469k | $41M | -19% | Mar 2024 |
|
American Century Companies | 264k | $260k | 100% | Mar 2024 |
|
Kohlberg Kravis Roberts & Co | 225k | $222k | 0% | Mar 2024 |
|
Oppenheimer Asset Management | 151k | $148k | -43% | Mar 2024 |
|
Stephens | 139k | $137k | 132% | Mar 2024 |
|
Calamos Wealth Management | 134k | $132k | 24% | Mar 2024 |
|
KBC Group NV | 100k | $99k | -50% | Mar 2024 |
|
Brian McDonald | 80k | $79k | -1% | Mar 2024 |
|
Us Bancorp | 73k | $72k | 0% | Mar 2024 |
|
Stonegate Investment Group | 50k | $49k | 285% | Mar 2024 |
|
Balboa Wealth Partners | 47k | $46k | 0% | Mar 2024 |
|
Northwestern Mutual Wealth Management Company | 32k | $31k | 0% | Mar 2024 |
|
Argent Trust | 25k | $25k | 0% | Mar 2024 |
|
SG Americas Securities | 22k | $2.1M | 0% | Mar 2024 |
|
Raymond James & Associates | 15k | $15k | 0% | Mar 2024 |
|
Prudent Investors Network | 12k | $12k | 100% | Mar 2024 |
|
Fox Hill Wealth Management | 11k | $11k | 100% | Mar 2024 |
|
Candriam Luxembourg S.C.A. | 250.00 | $246k | 0% | Mar 2024 |
|
Who sold out of Biomarin Pharma Inc convertible/?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
OZ Management | Dec 2023 | 35M | $35M |
Two Sigma Investments | Dec 2023 | 20M | $20M |
Centiva Capital | Dec 2023 | 11M | $10M |
RWC Asset Management | Dec 2023 | 10M | $9.9M |
SSI Investment Management | Sep 2023 | 8.7M | $8.5M |
Susquehanna International | Sep 2023 | 5.0M | $4.9M |
BlackRock | Sep 2023 | 3.3M | $3.2M |
La Banque Postale Asset Management SA | Dec 2023 | 2.2M | $2.1M |
Worth Venture Partners | Dec 2023 | 910k | $899k |
Russell Investments | Dec 2023 | 621k | $614k |
Ofi Invest Asset Management | Sep 2023 | 3.0k | $2.9M |